Evidence map›Paper›PMID 41827978›Full record

ArticleDiagnostics (Basel, Switzerland)2026

Plasmablastic Transformation of CLL/SLL: The Role of Early NGS Diagnosis and Targeted Multimodal Therapy.

Jelena Filipović, Sara Milošević, Tatjana Terzić, Thorsten Braun, Ramy Rahmé, Grégory Lazarian, Thami Benboubker, Michael Soussan, Antoine Martin

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jelena FilipovićInstitute of Pathology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-2054-4019
Sara MiloševićFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0009-0008-0474-3692
Tatjana TerzićInstitute of Pathology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Thorsten BraunDepartment of Hematology, Université Paris Nord, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Avicenne, 93000 Bobigny, France.
Ramy RahméDepartment of Hematology, Université Paris Nord, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Avicenne, 93000 Bobigny, France.
Grégory LazarianBiological Hematology Department, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Avicenne, 93000 Bobigny, France.
Thami BenboubkerBiological Hematology Department, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Avicenne, 93000 Bobigny, France.
Michael SoussanDepartment of Nuclear Medicine, Université Paris Nord, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Avicenne, 93000 Bobigny, France.
Antoine MartinDepartment of Anatomical and Cytological Pathology, Université Paris Nord, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Avicenne, 93000 Bobigny, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CD38 and BTK-targeted therapyNGS-based clonal confirmationPBLSLL

Identifiers

PMID41827978
PMCPMC12984125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.